Opin vísindi

Fletta eftir höfundi "Barkardóttir, Rósa Björk"

Fletta eftir höfundi "Barkardóttir, Rósa Björk"

Röðun: Raða: Niðurstöður:

  • Csuka, Dorottya; Freysteinsdóttir, Edda Sigríður; Jóhannesdóttir, Guðrún; Agnarsson, Bjarni Agnar; Jóhannsson, Óskar Þór; Barkardóttir, Rósa Björk; Arason, Aðalgeir (2024-02-08)
    Although a number of high-risk breast cancer genes have been identified, including BRCA1 and BRCA2, the risk profile of many high-risk families cannot be explained using known breast cancer genes. Previously, we have shown strong indications of new ...
  • Vidarsdottir, Linda; Olafsdottir, Elinborg J.; Barkardóttir, Rósa Björk; Bjarnadóttir, Ólöf Kristjana; Jónasson, Jón Gunnlaugur; Sigurdsson, Stefan; Tryggvadottir, Laufey (2023-11-30)
    Estrogen receptor-positive (ER+) breast cancer generally confers a more favorable prognosis than ER-negative cancer, however, a different picture is emerging for BRCA2 mutation carriers and young patients. We used nationwide data from population-based ...
  • Reynisdóttir, Inga; Arason, Aðalgeir; Freysteinsdóttir, Edda Sigríður; Kristjánsdóttir, Sigrún Bærings; Hilmarsdóttir, Bylgja; Traustadóttir, Gunnhildur Ásta; Jóhannsson, Óskar Þór; Agnarsson, Bjarni Agnar; Barkardóttir, Rósa Björk (2023-08)
    The disruption of endoplasmic reticulum (ER) homeostasis occurs in many human diseases. Atlastins (ATLs) maintain the branched network of the ER. The dysregulation of ATL2, located at ER network junctions, has been associated with cancer. ATL2 is ...
  • GEMO Study Collaborators; Barkardóttir, Rósa Björk; Jóhannsson, Óskar Þór (2022-01-14)
    Polygenic risk scores (PRS) for epithelial ovarian cancer (EOC) have the potential to improve risk stratification. Joint estimation of Single Nucleotide Polymorphism (SNP) effects in models could improve predictive performance over standard approaches ...